Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study
Tóm tắt
This article aims to evaluate the possible effect of obesity on quality of life, psychological status, and other clinical variables in Psoriatic arthritis (PsA). PsA patients have been recruited by the Turkish League Against Rheumatism-Network from various centers in Turkey in this cross-sectional study. Patients with a body mass index (BMI) ≥ of 30 kg/m2 were considered obese. Differences among patients with regard to obesity status were assessed with health-related quality of life measures (PsA Quality of Life Questionnaire [PsAQoL]), psychological status (Hospital Anxiety and Depression Scale [HADS]), and disease activity parameters (the Disease Activity index for PSoriatic Arthritis [DAPSA], Disease Activity Score 28-C-reactive protein [DAS28-CRP], Bath Ankylosing Spondylitis Disease Activity Index [BASDAI], Psoriasis Area and Severity Index [PASI]), physical functions (Ankylosing Spondylitis Functional Index [BASFI], Health Assessment Questionnaire [HAQ], and Health Assessment Questionnaire for the spondyloarthropathies [HAQ-S]). Pain was assessed using visual analog scale of pain (VAS-P), and fatigue was evaluated using visual analog scale of fatigue (VAS-F) and Functional Assessment of Chronic Illness Therapy (FACIT). A total of 1033 patients with PsA, 650 (62.9%) non-obese and 383 (37.1%) obese were included in the study. The PsAQoL, HADS-Anxiety, HADS-Depression, DAPSA, DAS28-CRP, BASDAI, BASFI, HAQ and HAQ-S scores of the obese group were higher than the non-obese group (p < 0.05). VAS-P and PASI scores were similar between group of patients with and without obesity. Obese patients had higher median scores of VAS-F and FACIT than non-obese patients (p < 0.05). Linear regression analysis showed that BMI affects the quality of life, depression, and disease activity. Consequently, obesity has significant associations with higher disease activity, lower QoL, risk of anxiety, depression, and fatigue. Therefore, obesity should also be taken into account in the management of PsA patients.
Tài liệu tham khảo
Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376(10):957–970. https://doi.org/10.1056/NEJMra1505557
Queiro R, Lorenzo A, Tejon P, Coto P, Pardo E (2019) Obesity in psoriatic arthritis: comparative prevalence and associated factors. Medicine (Baltimore) 98(28):e16400. https://doi.org/10.1097/MD.0000000000016400
Solomon DH, Love TJ, Canning C, Schneeweiss S (2010) Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 69(12):2114–2117. https://doi.org/10.1136/ard.2009.125476
Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD (2011) Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res 63(12):1729–1735. https://doi.org/10.1002/acr.20627
Perez-Chada LM, Merola JF (2020) Comorbidities associated with psoriatic arthritis: review and update. Clin Immunol (Orlando, Fla) 214:108397. https://doi.org/10.1016/j.clim.2020.108397
Gupta S, Syrimi Z, Hughes DM, Zhao SS (2021) Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int 41(2):275–284. https://doi.org/10.1007/s00296-020-04775-2
Bhole VM, Choi HK, Burns LC, Vera Kellet C, Lacaille DV, Gladman DD, Dutz JP (2012) Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) 51(3):552–556. https://doi.org/10.1093/rheumatology/ker349
Divella R, De Luca R, Abbate I, Naglieri E, Daniele A (2016) Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer 7(15):2346–2359. https://doi.org/10.7150/jca.16884
Van Raemdonck K, Umar S, Szekanecz Z, Zomorrodi RK, Shahrara S (2018) Impact of obesity on autoimmune arthritis and its cardiovascular complications. Autoimmun Rev 17(8):821–835. https://doi.org/10.1016/j.autrev.2018.02.007
Porta S, Otero-Losada M, Kölliker Frers RA, Cosentino V, Kerzberg E, Capani F (2020) Adipokines, cardiovascular risk, and therapeutic management in obesity and psoriatic arthritis. Front Immunol 11:590749. https://doi.org/10.3389/fimmu.2020.590749
Love TJ, Zhu Y, Zhang Y, Wall-Burns L, Ogdie A, Gelfand JM, Choi HK (2012) Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis 71(8):1273–1277. https://doi.org/10.1136/annrheumdis-2012-201299
Li W, Han J, Qureshi AA (2012) Obesity and risk of incident psoriatic arthritis in US women. Ann Rheum Dis 71(8):1267–1272. https://doi.org/10.1136/annrheumdis-2011-201273
Azevedo S, Santos-Faria D, Leite Silva J, Ramos Rodrigues J, Sousa Neves J, Peixoto D, Tavares-Costa J, Alcino S, Afonso C, Teixeira F (2019) Obesity, metabolic syndrome and other comorbidities in rheumatoid arthritis and psoriatic arthritis: influence on disease activity and quality of life. Acta Reumatol Portuguesa 44(4):322–324
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673. https://doi.org/10.1002/art.21972
McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ (2004) Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 63(2):162–169. https://doi.org/10.1136/ard.2003.006296
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS (2010) Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 69(8):1441–1447. https://doi.org/10.1136/ard.2009.122259
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21(12):2286–2291
Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285
Fries JF, Spitz PW, Young DY (1982) The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 9(5):789–793
Daltroy LH, Larson MG, Roberts NW, Liang MH (1990) A modification of the health assessment questionnaire for the spondyloarthropathies. J Rheumatol 17(7):946–950
Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Exum ML, Clark AR, Nurre L (1996) The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 106(1):183–186. https://doi.org/10.1111/1523-1747.ep12329912
Webster K, Cella D, Yost K (2003) The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1:79. https://doi.org/10.1186/1477-7525-1-79
Coto-Segura P, Eiris-Salvado N, González-Lara L, Queiro-Silva R, Martinez-Camblor P, Maldonado-Seral C, García-García B, Palacios-García L, Gomez-Bernal S, Santos-Juanes J, Coto E (2013) Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis. Br J Dermatol 169(4):783–793. https://doi.org/10.1111/bjd.12473
Dubreuil M, Rho YH, Man A, Zhu Y, Zhang Y, Love TJ, Ogdie A, Gelfand JM, Choi HK (2014) Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Rheumatology (Oxford) 53(2):346–352. https://doi.org/10.1093/rheumatology/ket343
Haroon M, Gallagher P, Heffernan E, FitzGerald O (2014) High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease. J Rheumatol 41(7):1357–1365. https://doi.org/10.3899/jrheum.140021
Ogdie A, Schwartzman S, Husni ME (2015) Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol 27(2):118–126. https://doi.org/10.1097/bor.0000000000000152
Loganathan A, Kamalaraj N, El-Haddad C, Pile K (2021) Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis. Int J Rheum Dis. https://doi.org/10.1111/1756-185x.14147
Labitigan M, Bahče-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, Putterman C, Broder A (2014) Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res 66(4):600–607. https://doi.org/10.1002/acr.22185
Thomsen RS, Nilsen TIL, Haugeberg G, Gulati AM, Kavanaugh A, Hoff M (2021) Adiposity and physical activity as risk factors for developing psoriatic arthritis: longitudinal data from a population-based study in Norway. Arthritis Care Res 73(3):432–441. https://doi.org/10.1002/acr.24121
Soltani-Arabshahi R, Wong B, Feng BJ, Goldgar DE, Duffin KC, Krueger GG (2010) Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol 146(7):721–726. https://doi.org/10.1001/archdermatol.2010.141
Nas K, Kiliç E, Tekeoğlu İ, Keskin Y, Çevik R, Sargin B, Acer Kasman S, Alkan H, Sahin N, Cengiz G, Cüzdan N, Albayrak Gezer İ, Keskin D, Mülkoglu C, Reşorlu H, Ataman Ş, Bal A, Baykul M, Duruöz MT, Küçükakkaş O, Yurdakul OV, Alkan Melikoğlu M, Ayhan FF, Bodur H, Çaliş M, Çapkin E, Devrimsel G, Gök K, Hizmetli S, Kamanlı A, Kocabaş H, Kutluk Ö, Şen N, Şendur ÖF, Toprak M, Tolu S, Tuncer T (2021) The effect of gender on disease activity and clinical characteristics in patients with axial psoriatic arthritis. Mod Rheumatol 31(4):869–874. https://doi.org/10.1080/14397595.2020.1812870
Kalyoncu U, Bayindir Ö, Ferhat Öksüz M, Doğru A, Kimyon G, Tarhan EF, Erden A, Yavuz Ş, Can M, Çetin GY, Kılıç L, Küçükşahin O, Omma A, Ozisler C, Solmaz D, Bozkirli ED, Akyol L, Pehlevan SM, Gunal EK, Arslan F, Yılmazer B, Atakan N, Aydın SZ (2017) The psoriatic arthritis registry of Turkey: results of a multicentre registry on 1081 patients. Rheumatology (Oxford) 56(2):279–286. https://doi.org/10.1093/rheumatology/kew375
Eder L, Thavaneswaran A, Chandran V, Cook RJ, Gladman DD (2015) Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Ann Rheum Dis 74(5):813–817. https://doi.org/10.1136/annrheumdis-2013-204448
Moroni L, Farina N, Dagna L (2020) Obesity and its role in the management of rheumatoid and psoriatic arthritis. Clin Rheumatol 39(4):1039–1047. https://doi.org/10.1007/s10067-020-04963-2
Kumthekar A, Ogdie A (2020) Obesity and psoriatic arthritis: a narrative review. Rheumatol Ther 7(3):447–456. https://doi.org/10.1007/s40744-020-00215-6
Klingberg E, Bilberg A, Björkman S, Hedberg M, Jacobsson L, Forsblad-d’Elia H, Carlsten H, Eliasson B, Larsson I (2019) Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study. Arthritis Res Ther 21(1):17. https://doi.org/10.1186/s13075-019-1810-5
Ballegaard C, Skougaard M, Guldberg-Møller J, Nissen CV, Amris K, Jørgensen TS, Dreyer L, Kristensen LE (2021) Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: a clinical cohort study. Rheumatology (Oxford) 60(7):3289–3300. https://doi.org/10.1093/rheumatology/keaa780
Michelsen B, Uhlig T, Sexton J, van der Heijde D, Hammer HB, Kristianslund EK, Wierød A, Bakland G, Rødevand E, Krøll F, Loge JH, Haugeberg G, Kvien TK (2018) Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls. Ann Rheum Dis 77(9):1290–1294. https://doi.org/10.1136/annrheumdis-2018-213286
Wervers K, Luime JJ, Tchetverikov I, Gerards AH, Kok MR, Appels CWY, van der Graaff WL, van Groenendael J, Korswagen LA, Veris-van Dieren JJ, Hazes JMW, Vis M (2018) Influence of disease manifestations on health-related quality of life in early psoriatic arthritis. J Rheumatol 45(11):1526–1531. https://doi.org/10.3899/jrheum.171406
Azad N, Gondal M, Abbas N (2008) Frequency of depression and anxiety in patients attending a rheumatology clinic. J College Phys Surg Pak: JCPSP 18(9):569–573
Geenen R, Newman S, Bossema ER, Vriezekolk JE, Boelen PA (2012) Psychological interventions for patients with rheumatic diseases and anxiety or depression. Best Pract Res Clin Rheumatol 26(3):305–319. https://doi.org/10.1016/j.berh.2012.05.004
Husni ME, Merola JF, Davin S (2017) The psychosocial burden of psoriatic arthritis. Semin Arthritis Rheum 47(3):351–360. https://doi.org/10.1016/j.semarthrit.2017.05.010
Peterson S, Piercy J, Blackburn S, Sullivan E, Karyekar CS, Li N (2019) The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis. BMC Rheumatol 3:43. https://doi.org/10.1186/s41927-019-0092-5
Bavière W, Deprez X, Houvenagel E, Philippe P, Deken V, Flipo RM, Paccou J (2020) Association between comorbidities and quality of life in psoriatic arthritis: results from a multicentric cross-sectional study. J Rheumatol 47(3):369–376. https://doi.org/10.3899/jrheum.181471
Duruöz MT, Gezer HH, Nas K, Kilic E, Sargin B, Acer Kasman S, Alkan H, Sahin N, Cengiz G, Cuzdan N, Albayrak Gezer İ, Keskin D, Mulkoglu C, Resorlu H, Ataman S, Bal A, Kucukakkas O, Yurdakul OV, Melikoglu MA, Ayhan FF, Baykul M, Bodur H, Calis M, Capkin E, Devrimsel G, Gök K, Hizmetli S, Kamanlı A, Keskin Y, Ecesoy H, Kutluk Ö, Sen N, Sendur ÖF, Tekeoglu İ, Tolu S, Toprak M, Tuncer T (2020) The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network. Rheumatol Int 40(11):1803–1815. https://doi.org/10.1007/s00296-020-04628-y
Kotsis K, Voulgari PV, Tsifetaki N, Machado MO, Carvalho AF, Creed F, Drosos AA, Hyphantis T (2012) Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res 64(10):1593–1601. https://doi.org/10.1002/acr.21725
McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, Gladman DD (2014) Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol 41(5):887–896. https://doi.org/10.3899/jrheum.130797
Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN (2008) Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 67(5):672–676. https://doi.org/10.1136/ard.2007.073932
Højgaard P, Glintborg B, Kristensen LE, Gudbjornsson B, Love TJ, Dreyer L (2016) The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries. Rheumatology (Oxford) 55(12):2191–2199. https://doi.org/10.1093/rheumatology/kew326
Eder L, Abji F, Rosen CF, Chandran V, Gladman DD (2017) The association between obesity and clinical features of psoriatic arthritis: a case-control study. J Rheumatol 44(4):437–443. https://doi.org/10.3899/jrheum.160532
di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Scarpa R, di Minno G (2013) Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis. Arthritis Care Res 65(1):141–147. https://doi.org/10.1002/acr.21711
Scher JU, Ogdie A, Merola JF, Ritchlin C (2019) Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol 15(3):153–166. https://doi.org/10.1038/s41584-019-0175-0
George MD, Giles JT, Katz PP, England BR, Mikuls TR, Michaud K, Ogdie-Beatty AR, Ibrahim S, Cannon GW, Caplan L, Sauer BC, Baker JF (2017) Impact of obesity and adiposity on inflammatory markers in patients with rheumatoid arthritis. Arthritis Care Res 69(12):1789–1798. https://doi.org/10.1002/acr.23229